electroCore (ECOR) Non-Current Debt (2020 - 2026)

Name: electroCore (ECOR) Non-Current Debt (2020 - 2026) | Business Quant
Creator: Business Quant

electroCore's quarterly Non-Current Debt came in at $6.4 million in Q1 2026, down 2.57% quarter-over-quarter from $6.6 million in Q4 2025.

electroCore has reported Non-Current Debt for 4 years, with the latest figure at $6.4 million in Q1 2026.

For the quarter ending Q1 2026, Non-Current Debt changed N/A year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (changed N/A YoY), and the FY2025 full-year result was $6.6 million, changed N/A from the prior year.
Non-Current Debt for Q1 2026 stood at $6.4 million, down from $6.6 million in the prior quarter.
The five-year high for Non-Current Debt was $6.6 million in Q4 2025, with the low at $6.4 million in Q1 2026.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	29.64 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	14.22 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	27.88 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	10.99 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	598.50 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	8.07 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	10.13 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	1.81 Bn
10	electroCore	92,394.96	-8.79 Mn	8.36 Mn	6.44 Mn

Download Data 🔒